Cystic fibrosis and noninvasive liver fibrosis assessment methods in children.


Journal

Pediatric research
ISSN: 1530-0447
Titre abrégé: Pediatr Res
Pays: United States
ID NLM: 0100714

Informations de publication

Date de publication:
01 2022
Historique:
received: 28 05 2020
accepted: 08 02 2021
revised: 27 01 2021
pubmed: 19 3 2021
medline: 29 3 2022
entrez: 18 3 2021
Statut: ppublish

Résumé

Noninvasive assessments of liver fibrosis are currently used to evaluate cystic fibrosis (CF)-related liver disease. However, there is scarce data regarding their repeatability and reproducibility, especially in children with CF. The present study aimed to evaluate the repeatability and reproducibility of transient elastography (TE) (FibroScan®) and point shear-wave elastography using virtual touch quantification (pSWE VTQ) in children with CF. TE and pSWE VTQ were performed in 56 children with CF by two different operators. Analysis of repeatability and reproducibility was available in 33 patients for TE and 46 patients for pSWE VTQ. Intra- and interobserver agreement were assessed using the intraclass correlation coefficient (ICC) and their 95% confidence interval (CI), and Bland and Altman graphs. For TE, ICC was 0.91 (0.83-0.95) for intraobserver agreement and 0.92 (95% CI: 0.86-0.96) for interobserver agreement. For pSWE VTQ, ICC was 0.83 (0.72-0.90) for intraobserver agreement and 0.67 (0.48-0.80) for interobserver agreement. Both technics can be proposed in the follow-up of patients, according to their availability in CF centers. This study shows that TE and pSWE VTQ are reliable methods to evaluate liver fibrosis in children with CF. This study shows for the first time that TE and pSWE VTQ are both repeatable and reproducible in children with CF. These data indicate that both TE and pSWE VTQ can be proposed for the follow-up of patients with CF, according to their availability in each CF center.

Sections du résumé

BACKGROUND
Noninvasive assessments of liver fibrosis are currently used to evaluate cystic fibrosis (CF)-related liver disease. However, there is scarce data regarding their repeatability and reproducibility, especially in children with CF. The present study aimed to evaluate the repeatability and reproducibility of transient elastography (TE) (FibroScan®) and point shear-wave elastography using virtual touch quantification (pSWE VTQ) in children with CF.
METHODS
TE and pSWE VTQ were performed in 56 children with CF by two different operators. Analysis of repeatability and reproducibility was available in 33 patients for TE and 46 patients for pSWE VTQ. Intra- and interobserver agreement were assessed using the intraclass correlation coefficient (ICC) and their 95% confidence interval (CI), and Bland and Altman graphs.
RESULTS
For TE, ICC was 0.91 (0.83-0.95) for intraobserver agreement and 0.92 (95% CI: 0.86-0.96) for interobserver agreement. For pSWE VTQ, ICC was 0.83 (0.72-0.90) for intraobserver agreement and 0.67 (0.48-0.80) for interobserver agreement.
CONCLUSIONS
Both technics can be proposed in the follow-up of patients, according to their availability in CF centers.
IMPACT
This study shows that TE and pSWE VTQ are reliable methods to evaluate liver fibrosis in children with CF. This study shows for the first time that TE and pSWE VTQ are both repeatable and reproducible in children with CF. These data indicate that both TE and pSWE VTQ can be proposed for the follow-up of patients with CF, according to their availability in each CF center.

Identifiants

pubmed: 33731812
doi: 10.1038/s41390-021-01427-4
pii: 10.1038/s41390-021-01427-4
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

223-229

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2021. The Author(s), under exclusive licence to the International Pediatric Research Foundation, Inc.

Références

Cystic Fibrosis Foundation. Patient Registry, 2014 Annual Data Report to the Center Directors, Bethesda, Maryland (p. 73). https://www.cff.org/2014-Annual-Data-Report.pdf (2014).
Lamireau, T. et al. Epidemiology of liver disease in cystic fibrosis: a longitudinal study. J. Hepatol. 41, 920–925 (2004).
pubmed: 15582124 doi: 10.1016/j.jhep.2004.08.006
Debray, D. et al. Cystic fibrosis-related liver disease: research challenges and future perspectives. J. Pediatr. Gastroenterol. Nutr. 65, 443–448 (2017).
pubmed: 28753176 doi: 10.1097/MPG.0000000000001676
Boëlle, P. Y. et al. Cystic fibrosis liver disease: outcomes and risk factors in a large cohort of French patients. Hepatology 69, 1648–1656 (2019).
pubmed: 30058245 doi: 10.1002/hep.30148
Debray, D. et al. Best practice guidance for the diagnosis and management of cystic fibrosis-associated liver disease. J. Cyst. Fibros. 10, S29–S36 (2011).
pubmed: 21658639 doi: 10.1016/S1569-1993(11)60006-4
de Lédinghen, V. & Vergniol, J. Transient elastography for the diagnosis of liver fibrosis. Expert Rev. Med. Dev. 7, 811–823 (2010).
doi: 10.1586/erd.10.46
Witters, P. et al. Non-invasive liver elastography (Fibroscan) for detection of cystic fibrosis-associated liver disease. J. Cyst. Fibros. 8, 392–399 (2009).
pubmed: 19733131 doi: 10.1016/j.jcf.2009.08.001
Rath, T. et al. TIMP-1/-2 and transient elastography allow non invasive diagnosis of cystic fibrosis associated liver disease. Dig. Liver Dis. 44, 780–787 (2012).
pubmed: 22652148 doi: 10.1016/j.dld.2012.04.008
Menten, R. et al. Transient elastography in patients with cystic fibrosis. Pediatr. Radiol. 40, 1231–1235 (2010).
pubmed: 20135110 doi: 10.1007/s00247-009-1531-z
Malbrunot-Wagner, A. C. et al. Transient elastography and portal hypertension in pediatric patients with cystic fibrosis transient elastography and cystic fibrosis. J. Cyst. Fibros. 10, 338–342 (2011).
pubmed: 21550861 doi: 10.1016/j.jcf.2011.04.004
van der Feen, C., van der Doef, H. P. J., van der Ent, C. K. & Houwen, R. H. J. Ursodeoxycholic acid treatment is associated with improvement of liver stiffness in cystic fibrosis patients. J. Cyst. Fibros. 15, 834–838 (2016).
pubmed: 27481229 doi: 10.1016/j.jcf.2016.07.009
Sağlam, D. et al. Can point shear wave elastography be used as an early indicator of involvement? Evaluation of the pancreas and liver in children with cystic fibrosis. J. Ultrasound Med. 39, 1769–1776 (2020).
pubmed: 32309883 doi: 10.1002/jum.15281
Lam, S. et al. Transient elastography in the evaluation of cystic fibrosis-associated liver disease: systematic review and meta-analysis. J. Can. Assoc. Gastroenterol. 2, 71–80 (2019).
pubmed: 31294368 doi: 10.1093/jcag/gwy029
Dietrich, C. F. et al. EFSUMB Guidelines and recommendations on the clinical use of liver ultrasound elastography, update 2017 (long version). Ultraschall Med. 38, e48 (2017).
pubmed: 30176678 doi: 10.1055/a-0641-0076
Sullivan, D. C. et al. Metrology standards for quantitative imaging biomarkers. Radiology 277, 813–825 (2015).
pubmed: 26267831 doi: 10.1148/radiol.2015142202
Shrout, P. E. & Fleiss, J. L. Intraclass correlations: uses in assessing rater reliability. Psychol. Bull. 86, 420–428 (1979).
pubmed: 18839484 doi: 10.1037/0033-2909.86.2.420
Bland, J. M. & Altman, D. G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1, 307–310 (1986).
pubmed: 2868172 doi: 10.1016/S0140-6736(86)90837-8
Fraquelli, M. et al. Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease. Gut 56, 968–973 (2007).
pubmed: 17255218 pmcid: 1994385 doi: 10.1136/gut.2006.111302
Boursier, J. et al. Reproducibility of liver stiffness measurement by ultrasonographic elastometry. Clin. Gastroenterol. Hepatol. 6, 1263–1269 (2008).
pubmed: 18995217 doi: 10.1016/j.cgh.2008.07.006
de Lédinghen, V. et al. Liver stiffness measurement in children using FibroScan: feasibility study and comparison with Fibrotest, aspartate transaminase to platelets ratio index, and liver biopsy. J. Pediatr. Gastroenterol. Nutr. 45, 443–450 (2007).
pubmed: 18030211 doi: 10.1097/MPG.0b013e31812e56ff
Fitzpatrick, E., Quaglia, A., Vimalesvaran, S., Basso, M. S. & Dhawan, A. Transient elastography is a useful noninvasive tool for the evaluation of fibrosis in paediatric chronic liver disease. J. Pediatr. Gastroenterol. Nutr. 56, 72–76 (2013).
pubmed: 22922372 doi: 10.1097/MPG.0b013e31826f2760
Engelmann, G. et al. Feasibility study and control values of transient elastography in healthy children. Eur. J. Pediatr. 171, 353–360 (2012).
pubmed: 21861093 doi: 10.1007/s00431-011-1558-7
Castéra, L. et al. Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations. Hepatology 51, 828–835 (2010).
pubmed: 20063276
Karlas, T. et al. Non-invasive evaluation of cystic fibrosis related liver disease in adults with ARFI, transient elastography and different fibrosis scores. PLoS ONE 7, e42139 (2012).
pubmed: 22848732 pmcid: 3405060 doi: 10.1371/journal.pone.0042139
Nobili, V. et al. Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis. Hepatology 48, 442–448 (2008).
pubmed: 18563842 doi: 10.1002/hep.22376
Gominon, A. L. et al. Assessment of liver disease progression in cystic fibrosis using transient elastography. J. Pediatr. Gastroenterol. Nutr. 66, 455–460 (2018).
pubmed: 29112089 doi: 10.1097/MPG.0000000000001822
Matos, H., Trindade, A. & Noruegas, M. J. Acoustic radiation force impulse imaging in paediatric patients: normal liver values. J. Pediatr. Gastroenterol. Nutr. 59, 684–688 (2014).
pubmed: 25141232 doi: 10.1097/MPG.0000000000000539
Hanquinet, S., Courvoisier, D., Kanavaki, A., Dhouib, A. & Anooshiravani, M. Acoustic radiation force impulse imaging-normal values of liver stiffness in healthy children. Pediatr. Radiol. 43, 539–544 (2013).
pubmed: 23247632 doi: 10.1007/s00247-012-2553-5
Hanquinet, S. et al. Acoustic radiation force impulse (ARFI) elastography for the noninvasive diagnosis of liver fibrosis in children. Pediatr. Radiol. 43, 545–551 (2013).
pubmed: 23271404 doi: 10.1007/s00247-012-2595-8
Noruegas, M. J., Matos, H., Goncalves, I., Cipriano, M. A. & Sanches, C. Acoustic radiation force impulse-imaging in the assessment of liver fibrosis in children. Pediatr. Radiol. 42, 201–204 (2012).
pubmed: 22002843 doi: 10.1007/s00247-011-2257-2
Manco, M. et al. Pilot study on the use of acoustic radiation force impulse imaging in the staging of cystic fibrosis associated liver disease. J. Cyst. Fibros. 11, 427–432 (2012).
pubmed: 22538068 doi: 10.1016/j.jcf.2012.04.001
Behrens, C. B. et al. A pilot study of the characterization of hepatic tissue strain in children with cystic-fibrosis-associated liver disease (CFLD) by acoustic radiation force impulse imaging. Pediatr. Radiol. 43, 552–557 (2013).
pubmed: 23192669 doi: 10.1007/s00247-012-2560-6
Monti, L. et al. Acoustic radiation force impulse (ARFI) imaging with virtual touch tissue quantification in liver disease associated with cystic fibrosis in children. Radiol. Med. 117, 1408–1418 (2012).
pubmed: 22986694 doi: 10.1007/s11547-012-0874-y
Bota, S. et al. Meta-analysis: ARFI elastography versus transient elastography for the evaluation of liver fibrosis. Liver Int. 33, 1138–1147 (2013).
pubmed: 23859217 doi: 10.1111/liv.12240
Harris, N. et al. Acoustic radiation force impulse accuracy and the impact of hepatic steatosis on liver fibrosis staging. J. Med. Imaging Radiat. Oncol. 60, 587–592 (2016).
pubmed: 27324199 doi: 10.1111/1754-9485.12482
Bota, S. et al. Intra- and interoperator reproducibility of acoustic radiation force impulse (PSWE VTQ) elastography – preliminary results. Ultrasound Med. Biol. 38, 1103–1108 (2012).
pubmed: 22579536 doi: 10.1016/j.ultrasmedbio.2012.02.032
Friedrich-Rust, M. et al. Non-invasive measurement of liver and pancreas fibrosis in patients with cystic fibrosis. J. Cyst. Fibros. 12, 431–439 (2013).
pubmed: 23361108 doi: 10.1016/j.jcf.2012.12.013
Canas, T. et al. Hepatic and splenic acoustic radiation force impulse shear wave velocity elastography in children with liver disease associated with cystic fibrosis. Biomed. Res. Int. 2015, 517369 (2015).
pubmed: 26609528 pmcid: 4644813 doi: 10.1155/2015/517369
Kim, J. R. et al. The diagnostic performance of shear-wave elastography for liver fibrosis in children and adolescents: a systematic review and diagnostic meta-analysis. Eur. Radiol. 28, 1175–1186 (2018).
pubmed: 29018925 doi: 10.1007/s00330-017-5078-3
Franchi-Abella, S. et al. Feasibility and diagnostic accuracy of supersonic shear-wave elastography for the assessment of liver stiffness and liver fibrosis in children: a pilot study of 96 patients. Radiology 278, 554–562 (2016).
pubmed: 26305193 doi: 10.1148/radiol.2015142815
Calvopina, D. A. et al. Supersonic shear-wave elastography and APRI for the detection and staging of liver disease in pediatric cystic fibrosis. J. Cyst. Fibros. 19, 449–454 (2020).
pubmed: 31303380 doi: 10.1016/j.jcf.2019.06.017
Sigrist, R., Liau, J., Kaffas, A. E., Chammas, M. C. & Willmann, J. K. Ultrasound elastography: review of techniques and clinical applications. Theranostics 7, 1303–1329 (2017).
pubmed: 28435467 pmcid: 5399595 doi: 10.7150/thno.18650

Auteurs

Raphael Enaud (R)

Pediatric Hepatology and Gastroenterology Unit, Bordeaux University Hospital, Pellegrin-Enfants Hospital, Bordeaux, France.
Bordeaux University Hospital, Pellegrin-Enfants Hospital, Pediatric Cystic Fibrosis-Center (CRCM), Bordeaux, France.
INSERM, Centre de Recherche Cardio-thoracique de Bordeaux (U1045), University of Bordeaux, Bordeaux, France.

Eric Frison (E)

Unité de soutien méthodologique à la recherche clinique et épidémiologique, Service d'information médicale, Pôle Santé Publique, Bordeaux University Hospital, Bordeaux, France.
Clinical Investigation Centre (CIC 1401), Bordeaux University Hospital, Bordeaux, France.

Sophie Missonnier (S)

Pediatric Imaging Unit, Bordeaux University Hospital, Pellegrin-Enfants Hospital, Bordeaux, France.

Aude Fischer (A)

Pediatric Hepatology and Gastroenterology Unit, Bordeaux University Hospital, Pellegrin-Enfants Hospital, Bordeaux, France.

Victor de Ledinghen (V)

Hepatology Unit, Bordeaux University Hospital, Haut-Lévêque Hospital, Pessac, France.

Paul Perez (P)

Unité de soutien méthodologique à la recherche clinique et épidémiologique, Service d'information médicale, Pôle Santé Publique, Bordeaux University Hospital, Bordeaux, France.
Clinical Investigation Centre (CIC 1401), Bordeaux University Hospital, Bordeaux, France.

Stéphanie Bui (S)

Bordeaux University Hospital, Pellegrin-Enfants Hospital, Pediatric Cystic Fibrosis-Center (CRCM), Bordeaux, France.

Michael Fayon (M)

Bordeaux University Hospital, Pellegrin-Enfants Hospital, Pediatric Cystic Fibrosis-Center (CRCM), Bordeaux, France.
INSERM, Centre de Recherche Cardio-thoracique de Bordeaux (U1045), University of Bordeaux, Bordeaux, France.
Clinical Investigation Centre (CIC 1401), Bordeaux University Hospital, Bordeaux, France.

Jean-François Chateil (JF)

Pediatric Imaging Unit, Bordeaux University Hospital, Pellegrin-Enfants Hospital, Bordeaux, France.
CRMSB (UMR 5536), University of Bordeaux/CNRS, Bordeaux, France.

Thierry Lamireau (T)

Pediatric Hepatology and Gastroenterology Unit, Bordeaux University Hospital, Pellegrin-Enfants Hospital, Bordeaux, France. thierry.lamireau@chu-bordeaux.fr.
Clinical Investigation Centre (CIC 1401), Bordeaux University Hospital, Bordeaux, France. thierry.lamireau@chu-bordeaux.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH